Capital International Investors
TMO icon

Capital International Investors’s Thermo Fisher Scientific TMO Stock Holding History

Capital International Investors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6B Sell
3,182,151
-706,575
-18% -$339M 0.33% 69
2026
Q1 		$1.91B Buy
3,888,726
+2,968,583
+323% +$1.61B 0.45% 56
2025
Q4 		$533M Buy
920,143
+5,136
+0.6% +$2.9M 0.08% 169
2025
Q3 		$444M Buy
915,007
+5,698
+0.6% +$2.65M 0.07% 179
2025
Q2 		$369M Buy
+909,309
New +$380M 0.06% 181
2023
Q3 		– Sell
-43,231
Closed -$22.6M – 450
2023
Q2 		$22.6M Buy
43,231
+3
+0% +$1.62K 0.01% 379
2023
Q1 		$24.9M Buy
43,228
+10,211
+31% +$5.76M 0.01% 377
2022
Q4 		$18.2M Sell
33,017
-3
-0% -$1.59K ﹤0.01% 376
2022
Q3 		$16.7M Sell
33,020
-142
-0.4% -$79.5K ﹤0.01% 385
2022
Q2 		$18M Hold
33,162
– – ﹤0.01% 399
2022
Q1 		$19.6M Sell
33,162
-598,086
-95% -$344M ﹤0.01% 407
2021
Q4 		$421M Sell
631,248
-223,557
-26% -$140M 0.09% 200
2021
Q3 		$488M Buy
854,805
+82
+0% +$45K 0.11% 174
2021
Q2 		$431M Sell
854,723
-210,428
-20% -$99.3M 0.1% 187
2021
Q1 		$486M Buy
1,065,151
+135,100
+15% +$64.5M 0.12% 169
2020
Q4 		$433M Sell
930,051
-633,637
-41% -$297M 0.12% 166
2020
Q3 		$690M Sell
1,563,688
-352,844
-18% -$146M 0.21% 114
2020
Q2 		$694M Sell
1,916,532
-121,635
-6% -$40.8M 0.23% 117
2020
Q1 		$578M Buy
2,038,167
+475,631
+30% +$150M 0.24% 101
2019
Q4 		$508M Sell
1,562,536
-457,405
-23% -$139M 0.17% 130
2019
Q3 		$588M Sell
2,019,941
-522,631
-21% -$150M 0.22% 113
2019
Q2 		$747M Sell
2,542,572
-106,087
-4% -$29.2M 0.3% 94
2019
Q1 		$725M Buy
2,648,659
+232,219
+10% +$57.8M 0.31% 88
2018
Q4 		$541M Sell
2,416,440
-1,141,463
-32% -$268M 0.27% 95
2018
Q3 		$868M Buy
+3,557,903
New +$819M 0.4% 67

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors's TMO Position: Q2 2026 in Review

Capital International Investors reduced its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, selling an estimated $339M and leaving 3,182,151 shares worth $1.6B. The position accounts for 0.33% of the portfolio, ranked #69.

Capital International Investors first reported a position in TMO in Q3 2018 and has held it in 25 quarters since. The position peaked at $1.91B in Q1 2026. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Capital International Investors held 3,182,151 shares of Thermo Fisher Scientific worth $1.6B as of Q2 2026.
  • Capital International Investors sold 706,575 Thermo Fisher Scientific shares in Q2 2026, an estimated $339M.
  • Thermo Fisher Scientific made up 0.33% of Capital International Investors's portfolio in Q2 2026, its #69 holding.
  • Capital International Investors first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 25 quarters since.
  • Capital International Investors's Thermo Fisher Scientific position peaked at $1.91B in Q1 2026.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Capital International Investors's 13F filing for Q2 2026, filed 12 Aug 2026.